Cambrex on takeover hunt amid pharma fine chem consolidation
Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.
Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.
AMRI posted a Q4 loss on lower sales but predicts that contracting revenues and margins will increase in 2012 thanks to cost cutting measures and new contracts
BASi says its new sampling tech will allow for quicker, cheaper and more accurate animal testing through its “low-stress” lab.
United Drug has inked a four-year, €30m packaging services deal as it continues to grow the division, particularly in the US.
Pharma supply chain consortium Rx-360 has advised drugmakers to check their L-Arginine stocks, warning that a recent surge in demand could limit supplies.
Celerion has teamed up with Verified Clinical Trials (VCT), a group aiming to stop ‘professional patients’ enrolling in multiple trials.
GSK is developing tablets it can compress without excipients to cut the time taken to reach the clinic by up to nine months.